HealthDay News — The US Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they ...

The amended dosing regimen was approved based on results from a post hoc analysis of the phase 2 MagnetisMM-3 trial.

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

The single-arm, open-label DR-OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who ...

In 2022, the FDA had made the decision to ban the products because the applications lacked sufficient evidence to show they met a public health standard.

Topline data were announced from a phase 3 trial evaluating luspatercept-aamt plus Janus kinase 2 inhibitor (JAKi) therapy in adults with myelofibrosis-associated anemia receiving red blood cell (RBC) ...

New indication for Kerendia; investigational therapy shows promise for hypertension; Novolog interchangeable biosimilar gets approval; trial results for hormone-free contraceptive; Shingrix now ...

HealthDay News — US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has removed two senior officials who were appointed by President Donald Trump. Heather Flick Melanson, chief of ...

Even more concerning? The loss of data. The US funded most HIV tracking systems in Africa, and many have now stopped collecting patient and hospital records.

Some of the biggest increases in emergency room visits for COVID-19 have happened in the Pacific Northwest and the Southeast.

HealthDay News — Delays in diagnosis of hypertension are common and associated with delays in treatment initiation, according to a study published online July 14 in JAMA Network Open.

While officials pointed to the department’s $1.8 trillion budget as a reason for the cuts, experts said payroll represented less than 1% of that amount.